Short-term effects of ketogenic diet on anthropometric parameters, body fat distribution, and inflammatory cytokine production in GLUT1 deficiency syndrome

Nutrition

Volumn 31, Issue 7-8, 2015, Pages 981-987

  Bertoli, Simona ^a   Neri, Ilaria Giulini ^a   Trentani, Claudia ^b   Ferraris, Cinzia ^b   De Amicis, Ramona ^a   Battezzati, Alberto ^a   Veggiotti, Pierangelo ^b,c   De Giorgis, Valentina ^b   Tagliabue, Anna ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Adiponectin; Inflammatory cytokines; Ketogenic diet; Leptin; Visceral fat

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER; IL6 PROTEIN, HUMAN; LIPID;

ADIPOSE TISSUE; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KETOGENIC DIET; LIPID DIET; LONGITUDINAL STUDY; MALE; METABOLIC DISORDER; METABOLISM; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SCHOOL CHILD; SUBCUTANEOUS FAT; BLOOD; DEFICIENCY; DIET RESTRICTION; DIET THERAPY; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG EFFECTS; IMMUNOLOGY; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ADIPONECTIN; ADIPOSE TISSUE; ANTHROPOMETRY; BIOMARKERS; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; C-REACTIVE PROTEIN; CARBOHYDRATE METABOLISM, INBORN ERRORS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FASTING; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; KETOGENIC DIET; LEPTIN; LIPIDS; LONGITUDINAL STUDIES; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; SUBCUTANEOUS FAT; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945956280     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.02.017     Document Type: Article

References (41)

1. Tagliabue A., Bertoli S., Trentani C., Borrelli P., Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr 2012, 31:246-249.
2. Coppola G., Veggiotti P., Cusmai R., Bertoli S., Cardinali S., Dionisi-Vici C., et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 2002, 48:221-227.
3. Bertoli S., Cardinali S., Veggiotti P., Tagliabue A. Nutritional and pharmacological approach in the management of epilepsy: links between ketogenic diets and common AEDs. Curr Med Chem 2005, 5:113-123.
4. Klepper J. Glucose transporter deficiency syndrome (GLUT1 DS) and the ketogenic diet. Epilepsia 2008, 49:46-49.
5. De Giorgis V., Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure 2013, 22:803-811.
6. Klepper J., Leiendecker B. GLUT1 deficiency syndrome-2007 update. Dev Med Child Neurol 2007, 49:707-716.
7. Li X., Gonzalez O., Shen X., Barnhart S., Kramer F., Kanter J.E., et al. Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment. Arterioscler Thromb Vasc Biol 2013, 33:232-240.
8. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
9. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
10. Davignon J., Gan P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:11127-11132.
11. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
12. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
13. Kwiterovich P.O., Vining E.P., Pyzik P., Skolasky R., Freeman J.M. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003, 290:912-920.
14. Klepper J., Scheffer H., Leiendecker B., Gertsen E., Binder S., Leferink M., et al. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2-to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics 2005, 36:302-308.
15. Kapetanakis M., Liuba P., Odermarsky M., Lundgren J., Hallböök T. Effects of ketogenic diet on vascular function. Eur J Paediatr Neurol 2014, 18:489-494.
16. Rauchenzauner M., Klepper J., Leiendecker B., Luef G., Rostasy K., Ebenbichler C. The ketogenic diet in children with Glut1 deficiency syndrome and epilepsy. J Pediatr 2008, 153:716-718.
17. Gras D., Roze E., Caillet S., Méneret A., Doummar D., Billette de Villemeur T., et al. GLUT1 deficiency syndrome: an update. Rev Neurol (Paris) 2014, 170:91-99.
18. Ramm-Pettersen A., Nakken K.O., Skogseid I.M., Randby H., Skei E.B., BindoffL.A., et al. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 2013, 55:440-447.
19. Veggiotti P., Burlina A., Coppola G., Cusmai R., De Giorgis V., Guerrini R., et al. The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus. Epilepsia 2011, 52(Suppl 2):83-89.
20. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual 1988, Human Kinetics Books, Champaign, IL.
21. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC growth charts: United States. Available at:. Accessed March 31, 2015. http://www.cdc.gov/growthcharts/.
22. McCarthy H.D., Jarrett K.V., Crawley H.F. The development of waist circumference percentiles in British children aged 5.0 to 16.9 y. Eur J Clin Nutr 2001, 55:902-907.
23. Durnin J.V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974, 32:77-97.
24. Siri W.E. Body composition from fluid spaces and density: Analysis of methods. 1961. Nutrition 1993, 9:480-491. discussion 480, 492.
25. Weir J.B. New methods for calculating metabolic rate with special reference to protein metabolism. Nutrition 1990, 6:213-221.
26. Armellini F., Zamboni M., Rigo L., Todesco T., Bergamo-Andreis I.A., Procacci C., et al. The contribution of sonography to the measurement of intra- abdominal fat. J Clin Ultrasound 1990, 18:563-567.
27. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
28. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
29. Bergqvist A.G., Schall J.I., Gallagher P.R., Cnaan A., Stallings V.A. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 2005, 46:1810-1819.
30. LARN - livelli di Assunzione di Riferimento di Nutrienti ed energia per la popolazione italiana. Available at:. Accessed March 31, 2015. http://www.sinu.it/documenti/20121016_LARN_bologna_sintesi_prefinale.pdf.
31. Bergman R.N., Kim S.P., Catalano K.J., Hsu I.R., Chiu J.D., Kabir M., et al. Why visceral fat is bad: echanisms of the metabolic syndrome. Obes Res 2006, 14:16-19.
32. Gustafson B., Hammarstedt A., Andersson C.X., Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2276-2283.
33. Bertoli S., Cardinali S., Veggiotti P., Trentani C., Testolin G., Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr J 2006, 5:14.
34. Bertoli S., Trentani C., Ferraris C., De Giorgis V., Veggiotti P., Tagliabue A. Long- term effects of a ketogenic diet on body composition and bone mineralization in GLUT-1 deficiency syndrome: a case series. Nutrition 2014, 30:726-728.
35. Kang H.C., Chung D.E., Kim D.W., Kim H.D. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004, 45:1116-1123.
36. Bertoli S., Battezzati A., Tagliabue A. Ketogenic diet in children with intractable epilepsy: what about resting energy expenditure and growth?. Dev Med Child Neurol 2014, 56:806-807.
37. Ballaban-Gil K., Callahan C., O'Dell C., Pappo M., Moshé S., Shinnar S. Complications of the ketogenic diet. Epilepsia 1998, 39:744-748.
38. Bielohuby M., Sisley S., Sandoval D., Herbach N., Zengin A., Fischereder M., et al. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab 2013, 305:1059-1070.
39. Furth S.L., Casey J.C., Pyzik P.L., Neu A.M., Docimo S.G., Vining E.P., et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 2000, 15:125-128.
40. Sampath A., KossoffE.H., Furth S.L., Pyzik P.L., Vining E.P.G. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007, 22:375-378.
41. Freeman J.M., KossoffE.H., Hartman A.L. The ketogenic diet: one decade later. Pediatrics 2007, 119:535-543.